oxycodone has been researched along with alfentanil in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Carmichael, JP; Lee, MA | 1 |
| Calam, MJ; Gwynn, A; Perkins, P | 1 |
| Hwang, BM; Jang, JS; Kang, SS; Kim, SS; Kim, YK; Kwon, YS; Lee, NR; Lim, SY; Son, HJ | 1 |
| Mahmood, I | 1 |
| Dou, Z; Li, Y; Ma, J; Ni, J; Wang, Q; Yang, L | 1 |
2 review(s) available for oxycodone and alfentanil
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Oxycodone versus other opioid analgesics after laparoscopic surgery: a meta-analysis.
Topics: Alfentanil; Analgesics, Opioid; Fentanyl; Humans; Laparoscopy; Morphine; Oxycodone; Pain; Pain Management; Sufentanil | 2021 |
1 trial(s) available for oxycodone and alfentanil
| Article | Year |
|---|---|
A Comparison of Oxycodone and Alfentanil in Intravenous Patient-Controlled Analgesia with a Time-Scheduled Decremental Infusion after Laparoscopic Cholecystectomy.
Topics: Adolescent; Adult; Aged; Alfentanil; Analgesia, Patient-Controlled; Cholecystectomy, Laparoscopic; Double-Blind Method; Female; Humans; Male; Middle Aged; Narcotics; Oxycodone; Pain Measurement; Pain, Postoperative; Prospective Studies; Retrospective Studies; Statistics, Nonparametric; Time Factors; Treatment Outcome; Young Adult | 2016 |
6 other study(ies) available for oxycodone and alfentanil
| Article | Year |
|---|---|
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Symptoms of opioid withdrawal syndrome after switch from oxycodone to alfentanil.
Topics: Alfentanil; Analgesics, Opioid; Carcinoma, Squamous Cell; Female; Humans; Hyperhidrosis; Lung Neoplasms; Middle Aged; Oxycodone; Pain; Substance Withdrawal Syndrome | 2010 |
The role of specialist palliative care in managing patients with multimorbidity.
Topics: Aged; Alfentanil; Chronic Disease; Combined Modality Therapy; Comorbidity; England; Health Services Needs and Demand; Holistic Health; Home Care Services, Hospital-Based; Hospice Care; Humans; Male; Medicine; Oxycodone; Pain Management; Palliative Care; Physical Therapy Modalities | 2012 |
Extrapolation of Drug Clearance in Children ≤ 2 Years of Age from Empirical Models Using Data from Children (> 2 Years) and Adults.
Topics: Adult; Alfentanil; Amikacin; Busulfan; Ceftizoxime; Child, Preschool; Humans; Infant; Injections, Intravenous; Meperidine; Metabolic Clearance Rate; Models, Biological; Oxycodone; Propofol; Sufentanil; Theophylline; Tobramycin | 2020 |